Editor's Bio
Sue Bodine

Sue Bodine

Dr. Bodine recently moved to the University of Iowa from the University of California, Davis where she was a full Professor with joint appointments in the Departments of Neurobiology, Physiology and Behavior, and Physiology and Membrane Biology for fourteen years.  She has joined the University of Iowa Carver College of Medicine as a full Professor in the Department of Internal Medicine, Division of Endocrinology and Metabolism.  She will also have a position in the Fraternal Order of Eagles Diabetes Research Center.

Dr. Bodine received her B.S, M.S., and Ph.D. in 1985 from the University of California, Los Angeles, where she received a Graduate Woman of the Year award under the mentorship of Dr. Reggie Edgerton. Following a postdoctoral fellowship at UCLA, she joined the faculty at the University of California, San Diego School of Medicine in the Department of Orthopedic Surgery.

Since her initial academic appointment in 1988, Dr. Bodine has held positions in both academia and private industry. She worked at Regeneron Pharmaceuticals from 1996 to 2002, where she became Co-Director of the Muscle Biology Program and worked on the identification and development of targets to treat muscle atrophy. In 2003, she returned to academia and has continued to study the mechanisms that regulate skeletal muscle mass and function.

Dr. Bodine is a Neuromuscular Physiologist whose general field of study is skeletal muscle plasticity. Her primary research interests are in understanding the mechanisms that regulate skeletal muscle size under growth and atrophy conditions. Her lab is also interested in understanding the molecular and cellular mechanisms responsible for muscle’s adaptation to exercise and inactivity, and in determining the potential role for exercise in disease prevention and increased quality of life with aging. The long-term objective of her lab is to identify and develop therapies for the treatment of muscle atrophy under a variety of conditions. Her lab has been involved in the identification of the ubiquitin ligases, MuRF1 and MAFbx/atrogin-1 as key regulators of skeletal muscle atrophy, and in mTORC1 as a key regulator of skeletal muscle hypertrophy.

Dr. Bodine has served as an NIH study section member and Chair of the Skeletal Muscle and Exercise Physiology panel. She has served as a Councilor for the APS/Environmental and Exercise Physiology section (2013-16) and as an Associate Editor of the American Journal of Physiology, Endocrinology and Metabolism (2010-16), Journal of Applied Physiology (2011-14) and American Journal of Physiology, Cell Physiology (2016). In 2016 she joined the Editorial Board of Physiology.